Cargando…
Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo()
BACKGROUND: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. METHODS: Data for children aged 2 months to <18 years recrui...
Autores principales: | Hebert, Adelaide A., Rosen, Theodore, Albareda López, Núria, Zsolt, Ilonka, Masramon, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105648/ https://www.ncbi.nlm.nih.gov/pubmed/32258344 http://dx.doi.org/10.1016/j.ijwd.2019.10.008 |
Ejemplares similares
-
Retrospective Analysis of the Real-World Use of Topical Antimicrobials in the Paediatric Population with Impetigo in Italy: Focus on the Role of Ozenoxacin 1% Cream
por: Barbieri, Elisa, et al.
Publicado: (2023) -
Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria
por: López, Yuly, et al.
Publicado: (2021) -
The Use of Ozenoxacin in Pediatric Patients: Clinical Evidence, Efficacy and Safety
por: Davino, Giusy, et al.
Publicado: (2020) -
Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain
por: Rodríguez-Quintosa, Jaime, et al.
Publicado: (2022) -
Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis
por: López, Y., et al.
Publicado: (2019)